Form 8-K - Current report:
SEC Accession No. 0001477932-25-002406
Filing Date
2025-04-03
Accepted
2025-04-03 09:31:54
Documents
20
Period of Report
2025-04-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bglc_8k.htm   iXBRL 8-K 27782
2 ARTICLES OF AMENDMENT bglc_ex37.htm EX-3.7 2709
8 bglc_ex37img4.jpg GRAPHIC 96742
9 bglc_ex37img1.jpg GRAPHIC 143937
10 bglc_ex37img2.jpg GRAPHIC 119514
11 bglc_ex37img3.jpg GRAPHIC 146671
  Complete submission text file 0001477932-25-002406.txt   861002

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bglc-20250401.xsd EX-101.SCH 5874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20250401_lab.xml EX-101.LAB 15742
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20250401_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20250401_pre.xml EX-101.PRE 9996
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20250401_def.xml EX-101.DEF 2099
23 EXTRACTED XBRL INSTANCE DOCUMENT bglc_8k_htm.xml XML 4168
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41750 | Film No.: 25807712
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)